Apo2L/TRAIL and the Death Receptor 5 Agonist Antibody AMG 655 Cooperate to Promote Receptor Clustering and Antitumor Activity
Jonathan D. Graves(Ifm Therapeutics (United States)), Pamela M. Holland(Cambridge Scientific (United States)), Heather Douangpanya(Amgen (United States)), Daniel Branstetter(Amgen (United States)), Xiaoning Zhao(Amgen (United States)), Rommel Mallari(Amgen (United States)), Ian N. Foltz(Amgen (Canada)), Tzu-Hsuan Huang(Pfizer (United States)), Wesley Chang(California Institute of Technology), Alexander Long(Amgen (United States)), Jennifer J. Kordich(Amgen (United States)), Timothy J. Sullivan(Amgen (United States)), Xin Huang(Amgen (United States)), Julia Piasecki(Université Paris Cité), Thu Thi Dang(Amgen (United States)), Tammy L. Bush(Amgen (United States)), John M. Rossi(Amgen (United States)), Jason O’Neill(Amgen (United States))
Cited by 155
Related Papers
Oxygen Reduction Electrocatalyst Based on Strongly Coupled Cobalt Oxide Nanocrystals and Carbon Nanotubes
|Journal of the American Chemical Society|2012|791
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
|New England Journal of Medicine|2023|695
An ultrafast nickel–iron battery from strongly coupled inorganic nanoparticle/nanocarbon hybrid materials
|Nature Communications|2012|404
Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1
|The EMBO Journal|1998|380
Quantitative Comparison of Long-wavelength Alexa Fluor Dyes to Cy Dyes: Fluorescence of the Dyes and Their Bioconjugates
|Journal of Histochemistry & Cytochemistry|2003|373